These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 23639708

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Aspirin-exacerbated respiratory disease: clinical disease and diagnosis.
    Bochenek G, Niżankowska-Mogilnicka E.
    Immunol Allergy Clin North Am; 2013 May; 33(2):147-61. PubMed ID: 23639705
    [Abstract] [Full Text] [Related]

  • 24. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA, Stevenson DD, Simon RA.
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [Abstract] [Full Text] [Related]

  • 25. Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity.
    West PM, Fernández C.
    Ann Pharmacother; 2003 Oct; 37(10):1497-501. PubMed ID: 14519044
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The broken balance in aspirin hypersensitivity.
    Szczeklik A, Sanak M.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):145-55. PubMed ID: 16457808
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
    Waldram J, Walters K, Simon R, Woessner K, Waalen J, White A.
    J Allergy Clin Immunol; 2018 Jan 08; 141(1):250-256. PubMed ID: 28550988
    [Abstract] [Full Text] [Related]

  • 30. Recent advance in investigation of gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease.
    Kurosawa M, Yukawa T, Hozawa S, Mochizuki H.
    Allergol Immunopathol (Madr); 2015 Jan 08; 43(1):92-100. PubMed ID: 25224359
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nonsteroidal anti-inflammatory-induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in aspirin-exacerbated respiratory disease.
    Katial RK, Martucci M, Burnett T, Faino A, Finkas L, Liu S, Alam R.
    J Allergy Clin Immunol; 2016 Aug 08; 138(2):579-85. PubMed ID: 26915678
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of aspirin-sensitive respiratory disease--a two-compartment model.
    Farooque S, Lee T.
    Int Arch Allergy Immunol; 2007 Aug 08; 142(1):59-63. PubMed ID: 17016058
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization.
    Walters KM, Simon RA, Woessner KM, Wineinger NE, White AA.
    Ann Allergy Asthma Immunol; 2017 Jul 08; 119(1):71-76. PubMed ID: 28668243
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis.
    Stevens W, Buchheit K, Cahill KN.
    Curr Allergy Asthma Rep; 2015 Dec 08; 15(12):69. PubMed ID: 26475526
    [Abstract] [Full Text] [Related]

  • 40. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD, Mehra PK, White AA, Gupta S, Woessner KM, Simon RA.
    J Allergy Clin Immunol; 2005 Oct 08; 116(4):755-60. PubMed ID: 16210047
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.